Crossmark

A versatile and sensitive lateral flow immunoassay for the rapid diagnosis of visceral leishmaniasis

Crossref DOI link: https://doi.org/10.1007/s00216-018-1067-x

Published Online: 2018-04-23

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Anfossi, Laura

Di Nardo, Fabio

Profiti, Margherita

Nogarol, Chiara

Cavalera, Simone

Baggiani, Claudio

Giovannoli, Cristina

Spano, Giulia

Ferroglio, Ezio

Mignone, Walter

Rosati, Sergio
License Information

Text and Data Mining valid from 2018-04-23
More Information

Article History

Received: 27 February 2018

Revised: 26 March 2018

Accepted: 5 April 2018

First Online: 23 April 2018

Compliance with ethical standards

:

: The author Chiara Nogarol works at the company In3Diagnostic (L.go P. Braccini 2, Grugliasco (TO), Italy), which may commercialise the LFIA device. However, this does not alter the authors’ adherence to the principles of good scientific practice and to relevant policies on sharing data and materials. The authors declare that they have no other competing interests.

: Blood samples were obtained during routine activities at the Veterinary Teaching Hospital of the Department of Veterinary Science or by veterinary practitioners. The study utilized samples from dogs at a private kennel/small-animal veterinary clinics, and informed consent was obtained from the owner of each dog. The consent was provided in oral form. No additional permission was required. All procedures were conducted in accordance with EU Directive 2010/63/EU for animal experiments, as well as with the informed consent of the owner of the animal.